期刊文献+

CLSI三代头孢菌素新旧折点对判定肺炎克雷伯菌药物敏感性及产ESBLs菌株分布的影响 被引量:2

Antimicrobial susceptibility interpretation and distribution of extended-spectrum β-lactamases producers in Klebsiella pneumonia isolates according to CLSI 2009 and 2010 breakpoints of cefotaxime and cefiazidime
原文传递
导出
摘要 目的了解CLSI 2010(S20)及2009(S19)头孢他啶(CAZ)、头孢噻肟(CTX)新旧折点变化对本地区肺炎克雷伯菌药物敏感性及产超广谱β-内酰胺酶(ESBLs)菌株分布的影响。方法收集安徽医科大学第一附属医院临床分离的50株肺炎克雷伯菌;纸片扩散法测定菌株对CTX及CAZ的敏感性,CLSI表型确证试验确定产ESBLs菌株,改良三维试验检测CTX和/或CAZ耐药、非产ESBLs菌株的产酶情况。结果在S19折点下,CTX和CAZ耐药率分别为54.0%、30.0%;在S20折点下,耐药率分别为68.0%、42.0%。产ESBLs菌株总检出率为64.0%(32/50)。旧折点下,分别有81.3%、43.8%的产ESBLs菌株分布在CTX和CAZ耐药菌株中;新折点下,升高至100%、62.5%。2株对CTX和/CAZ耐药、非产ESBL菌株中,1株同时产ESBLs和AmpC酶,1株仅产AmpC酶。结论根据S20,肺炎克雷伯菌对CTX和CAZ的耐药率较S19均有所增高;并提高了耐药表型与产ESBLs菌株的一致性。产AmpC酶可影响表型确证试验对产ESBLs菌株的检出。 Objective To evaluate the influences of CLSI 2009 (S19) and 2010 ($20) breakpoints of cefotaxime (CTX) and cefiazidime (CAZ) on the antimicrobial susceptibility interpretation and distribution of extended-spectrum β-1actamases (ESBLs) producers in Klebsiella pneumonia isolates. Method Fifty K. pneumonia isolates were collected from the First Affiliated Hospital of Anhui Medical University in 2008. Antimicrobial susceptibility of those isolates were tested by disk diffusion method, and ESBLs producers were confirmed by the CLSI phenotypic confirmatory test. Susceptibility of K. pneumonia to CTX and CAZ as well as the distribution of ESBLs producers were analyzed according to the breakpoints of the S19 and S20, respectively. The modified three-dimensional extract test was used to detect the ESBLs-negative isolates with resistance to CTX and/or CAZ. Result According to the S19, the resistance rate to CTX and CAZ was 54.0% and 30.0%, respectively, while to the S20, the resistance rate was 68% and 42% , respectively. ESBLs producers were detected in 64.0% (32/50) of K. pneumonia. According to S19/S20 breakpoints, the distribution of ESBLs producers in CTX or CAZ resistant isolates was 81.3%/100.0% and 43.8%/62.5%, respectively. In ESBLs-negative producers, two were resistant to CTX and/or CAZ. One produced AmpC enzyme and ESBLs, the other only produced AmpC enzyme. Conclusion The resistance rate of CTX and CAZ increases according to new breakpoints (S20), and the consistency of the drug resistance and ESBLs phenotype is improved. Detection rate of ESBLs producers is influenced by AmpC-producing capability of those isolates.
出处 《中国微生态学杂志》 CAS CSCD 2012年第3期251-253,256,共4页 Chinese Journal of Microecology
基金 教育部科学研究重点项目(209059) 安徽省高等学校省级自然科学研究项目(KJ2011A180) 安徽省人社厅 卫生厅人才基金
关键词 CLSI 肺炎克雷伯菌 第三代头孢菌素 药物敏感性 ESBLs CLSI Klebsiella pneumonia Third cephalosporins Suscepbility Extended-spectrum β-lactamases
  • 相关文献

参考文献17

  • 1ANDES D,CRAIG W A.Treatment of infections with ESBL-producing organisms:pharmacokinetic and pharmacodynamic considerations[J].Clin Microbiol Infect,2005,11(6):10-17. 被引量:1
  • 2CRAIG W A,KIEM S,JONES R,et al.Impact of ESBLs on in vivo of four cephalosporins in the neutropenic mouse-thigh infection model,ab-str[C].#A-1318.In:Programs and Abstracts of the43rd Interscience Conference on Antimicrobial Agents and Chemotherapy.Chicago:ICAAC,2003:14-17. 被引量:1
  • 3PATERSON D L,KO W C,Van GOTTBERG A,et al.Outcome of cephalosporin treatment for serious infections due to apparently suscep-tible organisms producing extended-spectrum beta-lactamases:implica-tions for the clinical microbiology laboratory[J].J Clin Microbiol,2001,39(6):2206-2212. 被引量:1
  • 4BIN C,HUI W,RENTUAN Z,et a1.Outcome of cephalosporin treat-ment of bacteremia due to CTX-M-type extended-spectrumβ-lacta-mase-producing Escherichia coli[J].Diagn Microbiol Infect Dis,2006,56(4):351-357. 被引量:1
  • 5Clinical and Laboratory Standards Institute sixteenth informational sup-plement M100-S20Performance standards for antimicrobial susceptibil-ity testing[S].Wayne,PA:CLSI,2010. 被引量:1
  • 6Clinical and Laboratory Standards Institute sixteenth informational sup-plement M100-S19Performance standards for antimicrobial susceptibil-ity testing[S].Wayne,PA:CLSI,2009. 被引量:1
  • 7施金玲,蔡璇,李从荣,彭少华,李红霞,李艳.阴沟肠杆菌去阻遏持续高产AmpC酶和超广谱β-内酰胺酶的耐药调查[J].中华医院感染学杂志,2003,13(10):966-968. 被引量:17
  • 8GOOSSENS H.MYSTIC program:surmnary of European data from1997 to2000[J].Diagn Microbiol Infect Dis,2001,41(4):183-189. 被引量:1
  • 9余道军,李荣群,范建中,周田美,董晓勤,汪涛,胡洁.产ESBLs肺炎克雷伯菌的致病性及头孢他啶疗效分析[J].中国现代应用药学,2006,23(5):413-416. 被引量:5
  • 10POTTUMARTHY S,YU Y,SADER H S,et a1.Susceptibility testing accuracy of a CTX-M–type extended-spectrum organism-producing population of Enterobacteriaceae:intermethod analysis for9β-lactams[J].Diagn Microbiol Infect Dis,2005,53(2):131-141. 被引量:1

二级参考文献40

  • 1季淑娟,顾怡明,谭文涛,王丹丹,冯羡菊,周志慧,俞云松,陈亚岗,李兰娟.中国部分地区大肠埃希菌和肺炎克雷伯菌超广谱β内酰胺酶基因型研究[J].中华检验医学杂志,2004,27(9):590-593. 被引量:172
  • 2余道军,周田美,董晓勤,窦琳琳.产ESBLs细菌体外药敏试验结果报告探讨[J].江西医学检验,2005,23(1):56-58. 被引量:5
  • 3陈民钧,俞云松,王辉,徐英春.改进药敏折点标准 指导临床合理选择抗菌药物[J].中华检验医学杂志,2005,28(6):565-568. 被引量:17
  • 4Clinical and Laboratory Standards Institute.sixteenth informational supplement M100S20 Performance standards for antimicrobial susceptibility testing.Wayne,PA:CLSI,2010. 被引量:1
  • 5Clinical and Laboratory Standards Institute.sixteenth informational supplement M100S19 Performance standards for antimicrobial susceptibility testing.Wayne,PA:CLSI,2009. 被引量:1
  • 6Craig WA,Kiem S,Jones R,et al.Impact of ESBL on in vivo of four cephalosporins in the neutropenic mouse-thigh infection model,abstr #A-1318.In:Programs and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy.Chicago:ICAAC,2003,14-17. 被引量:1
  • 7Paterson DL,Ko WC,Von Gottberg A,et al.Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum betalactamases:implications for the clinical microbiology laboratory.J Clin Microbiol,2001,39:2206-2212. 被引量:1
  • 8Bin C,Hui W,Renyuan Z,et al.Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing escherichia coli.Diagn Microbiol Infect Dis,2006,56:351-357. 被引量:1
  • 9Tumidge J,Paterson DL.Setting and revising antibacterial susceptibility breakpoints.Clin Microbiol Rev,2007,20:391-408. 被引量:1
  • 10张杰,阮筠.抗菌素折点改变与临床关系.中国医学论坛报,2006-05-11(017). 被引量:1

共引文献86

同被引文献16

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部